BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu Y, Ma S, Ding W, Sun P, Zhou Q, Duan Y, Sartorius K. Resident Immune Cells of the Liver in the Tumor Microenvironment. Front Oncol 2022;12:931995. [DOI: 10.3389/fonc.2022.931995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan CY, Zhao ML, Wei YN, Zhao XH. Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities. Mol Ther Oncolytics 2023;28:212-29. [PMID: 36860815 DOI: 10.1016/j.omto.2023.02.001] [Reference Citation Analysis]
2 Shah DD, Dave BP, Patel PA, Chorawala MR, Patel VN, Shah PA, Patel MP. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Med Oncol 2023;40:84. [PMID: 36680649 DOI: 10.1007/s12032-023-01948-4] [Reference Citation Analysis]
3 Grottoli M, Carrega P, Zullo L, Dellepiane C, Rossi G, Parisi F, Barletta G, Zinoli L, Coco S, Alama A, Marconi S, Parodi M, Orecchia P, Bassi S, Vitale M, Mingari MC, Pfeffer U, Genova C, Pietra G. Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. Cancers (Basel) 2022;14:5046. [PMID: 36291830 DOI: 10.3390/cancers14205046] [Reference Citation Analysis]